This medical diagram illustrates the basal ganglia circuitry and its contributions to eye movement control. The schematic highlights the functional pathways originating in the Cortex and projecting to the Striatum (Caudate and Putamen). The 'direct pathway' is depicted as an inhibitory connection from the striatum to the Substantia Nigra pars reticulata (SNr) or Globus Pallidus internus (GPi). The 'indirect pathway' involves sequential projections from the striatum to the Globus Pallidus externus (GPe), the Subthalamic Nucleus (STN), and then to the SNr or GPi. The SNr serves as a critical convergence point, sending inhibitory signals to the Superior Colliculus (SC) in the midbrain to regulate saccades. The Substantia Nigra pars compacta (SNc) is shown providing dopaminergic modulation to the striatum. Below the brainstem, the diagram integrates peripheral visual components, including the eye, Optic Nerve (CN II) projecting to the SC, and Oculomotor Nerve (CN III). A color-coded legend indicates functional dynamics: red for excitatory, blue for inhibitory, and green for modulatory connections.

A pathophysiology diagram illustrating the motor regulatory functions of the basal ganglia. The image consists of a coronal brain section paired with text-based flowcharts detailing the 'Direct' and 'Indirect' pathways. In the anatomical illustration, key structures are color-coded: the Substantia Nigra pars compacta (SNpc) in brown/yellow, the Striatum (putamen and caudate) in pink and green, the Globus Pallidus interna (GPi) in cyan, the Globus Pallidus externa (GPe) in blue, and the Subthalamic Nuclei (STN) in gold. The 'Direct Pathway' list describes a sequence of dopaminergic potentiation and GABAergic inhibition involving the D1 receptors, leading to thalamic uninhibition and motor cortex activation. The 'Indirect Pathway' list outlines the more complex sequence involving D2 receptors, the GPe, and the STN, which normally modulates motor activity. The diagram highlights the role of neurotransmitters including dopamine, GABA, and glutamate in regulating muscle tone and movement. This educational material is relevant for understanding movement disorders like Parkinson’s disease and neuroleptic malignant syndrome.

This medical illustration presents a comparative pathophysiology diagram of the basal ganglia circuitry in a physiological state (A) and Parkinson’s Disease (B). The diagram utilizes a coronal brain section view to detail the dopaminergic (DA) regulation of movement. Key anatomical structures labeled include the Motor Cortex, Thalamus, Putamen (striatum), Substantia Nigra pars compacta (SNc), Substantia Nigra reticulata (SNr), Subthalamic Nucleus (STN), Globus Pallidus externa (GPe), and Globus Pallidus interna (GPi). The 'direct pathway' is depicted via D1-receptor-mediated inhibitory projections from the putamen directly to the GPi/SNr, facilitating movement. The 'indirect pathway' is shown via D2-receptor-mediated projections through the GPe and STN, ultimately inhibiting movement. Comparison A highlights healthy dopamine release from the SNc, while Comparison B illustrates the neurodegenerative depletion of dopamine (indicated by dashed lines), resulting in overactivity of the indirect pathway and increased inhibition of the thalamocortical loop. This educational visual explains the mechanistic basis for bradykinesia and motor symptoms in Parkinson’s Disease.

This medical illustration presents a pathophysiology diagram of the human brain in coronal section, focusing on the motor circuitry of the basal ganglia. The diagram maps the structural and functional relationships between the cerebral cortex, striatum (caudate nucleus and putamen), globus pallidus externa (GPe), globus pallidus interna (GPi), subthalamic nucleus (STN), substantia nigra (SN), and thalamus. Three primary signaling pathways are color-coded: the Direct Pathway (red), which facilitates movement; the Indirect Pathway (blue), which inhibits movement; and the Hyperdirect Pathway (green). The visual also utilizes distinct arrowheads to indicate neurotransmitter types: pointed arrows represent excitatory glutamatergic projections (e.g., from the cortex and STN), while T-shaped bars represent inhibitory GABAergic projections (e.g., from the striatum and globus pallidus). This anatomical model is essential for understanding neurodegenerative movement disorders such as Huntington’s Disease and Parkinsonism, specifically how striatal degeneration alters cortical excitation and inhibition loops.

This Comparison Chart displays triaxial acceleration signals recorded for clinical assessment, likely in the context of movement disorders such as Parkinson’s disease. The figure presents five stacked time-series plots corresponding to different anatomical regions: Right hand, Left hand, Right leg, Left leg, and Chest. Each plot tracks acceleration values (measured in g) across X, Y, and Z axes against a sample timeline (0 to 1100 samples). Key visual features include: - Hand Signals: Characterized by relatively low-amplitude, stable oscillations, indicating smoother movement patterns. - Leg Signals: Demonstrate significantly higher amplitude fluctuations and increased frequency, particularly in the X-axis, representing more dynamic or irregular gait and limb acceleration. - Chest Signals: Show the most stable, low-amplitude patterns across all three axes, reflecting central body mass stability during activity. This data is used in neurology and rehabilitation medicine to objectively quantify motor symptoms (e.g., tremor, bradykinesia, or gait disturbances) using wearable sensors. It supports automated symptom recognition and condition monitoring through algorithmic analysis of movement symmetry and intensity.

This composite educational graphic presents a comparison of functional connectivity in the sensorimotor cortex between patients with Huntington’s disease (HD) and Parkinson’s disease (PD). The left panel displays three orthogonal MRI views (axial, coronal, and sagittal) in radiological orientation, highlighting regions of interest in the sensorimotor cortex. Red-colored clusters indicate areas with statistically significant differences in functional connectivity (P < 0.05 to P < 0.001, corrected). The right panel features corresponding box plots showing parameter estimates (functional connectivity values) across four cohorts: healthy controls for HD (HCHD), HD patients, PD patients, and healthy controls for PD (HCPD). The data illustrates divergent pathological trends: HD carriers exhibit significantly lower functional connectivity (median = 14) compared to their controls (median = 50), whereas PD patients demonstrate higher functional connectivity (median = 45) compared to their matched controls (median = 23). Individual data points superimposed on the box plots indicate the variability within each group. This visual serves to teach the contrasting pathophysiology of sensorimotor network alterations in these two movement disorders.

A comparison chart containing six swarm plots illustrating the distribution of automated gait features across four MDS-UPDRS (Unified Parkinson's Disease Rating Scale) gait item 3.10 categories: 0 (Normal), 1 (Slight), 2 (Mild), and 3 (Moderate). The six analyzed gait features are Speed, Arm swing (velocity), Arm swing (amplitude), Postural control, Roughness (min), and Roughness (max). Each subplot shows individual data points (n=1457 total across categories) representing specific gait assessments. For Speed and Arm swing features, the data clusters show a clear downward trend as UPDRS severity increases, indicating reduced movement amplitude and velocity in more advanced Parkinsonian gait. Conversely, Roughness (min) and Roughness (max) plots demonstrate an upward trend and increased variance in higher UPDRS categories, indicating more erratic or irregular walking patterns. The visualization demonstrates the clinical relevance of these digital biomarkers in characterizing gait impairment levels, with each feature showing a statistically significant (p<0.001) difference in means between the clinical rating groups.